Literature DB >> 2952521

Release of immunoreactive atrial natriuretic factor from the isolated perfused rat lung.

J Gutkowska, M Cantin, J Genest, P Sirois.   

Abstract

The secretion of ANF by the rat lung was demonstrated in the present study. Four forms of immunoreactive ANF were detected in rat lung homogenates, including the 126 amino acid prohormone but only a low molecular mass peptide was released during lung perfusion. The released ANF inhibited forskolin-stimulated aldosterone secretion from rat zona glomerulosa cell suspensions, and this biological effect was comparable to that of the synthetic C-terminal part of the prohormone (Arg-101-Tyr-126).

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2952521     DOI: 10.1016/0014-5793(87)80005-4

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  5 in total

Review 1.  Atrial natriuretic peptide in peripheral organs other than the heart.

Authors:  A M Vollmar
Journal:  Klin Wochenschr       Date:  1990-07-17

2.  Lung is an important source of atrial natriuretic factor in experimental cardiomyopathy.

Authors:  J Gutkowska; M Nemer; M J Sole; J Drouin; P Sirois
Journal:  J Clin Invest       Date:  1989-05       Impact factor: 14.808

3.  Atrial and brain natriuretic peptides share binding sites on cultured cells from the rat trachea.

Authors:  S James; G Burnstock
Journal:  Cell Tissue Res       Date:  1991-09       Impact factor: 5.249

4.  Glucagon-Like Peptide 1 and Atrial Natriuretic Peptide in a Female Mouse Model of Obstructive Pulmonary Disease.

Authors:  Emilie Balk-Møller; Johanne Agerlin Windeløv; Berit Svendsen; Jenna Hunt; Seyed Mojtaba Ghiasi; Charlotte Mehlin Sørensen; Jens Juul Holst; Hannelouise Kissow
Journal:  J Endocr Soc       Date:  2019-12-19

5.  Intrinsic defence capacity and therapeutic potential of natriuretic peptides in pulmonary hypertension associated with lung fibrosis.

Authors:  R S Baliga; C J Scotton; S L Trinder; R C Chambers; R J MacAllister; A J Hobbs
Journal:  Br J Pharmacol       Date:  2014-07       Impact factor: 8.739

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.